Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07469462

The Effects of High-dose Vitamin B6 on Depression and Anxiety Symptoms

An EEG Study to Investigate the Effect of High-dose Vitamin B6 Supplementation on Neural Activity in Relation to Depression and Anxiety Symptoms.

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
44 (estimated)
Sponsor
University of Reading · Academic / Other
Sex
All
Age
18 Years – 41 Years
Healthy volunteers
Accepted

Summary

This clinical trial investigates the effects of Vitamin B6 supplementation on neural inhibition using electroencephalography (EEG), in relation to depression and anxiety symptoms in participants from the general population with a relatively high level of symptoms at baseline. Researchers will compare a placebo group to high-dose Vitamin B6 to test the hypothesis that Vitamin B6 moves the excitation/inhibition balance towards inhibition.

Detailed description

The primary question this trial aims to answer is: \- Compared to placebo, in people experiencing depression and anxiety symptoms, does high-dose Vitamin B6 supplementation change the excitation/inhibition balance towards inhibition as measured using electroencephalography (EEG)? Secondary research questions are: * Compared to placebo, does high-dose Vitamin B6 supplementation reduce symptoms of depression and anxiety? * Do individuals with lower Vitamin B6 levels at baseline, as measured in blood plasma, show a larger effect of high dose Vitamin B6 on the EEG measures or symptoms? * Compared to placebo, does high-dose Vitamin B6 intervention lead to an increase in hand grip strength? This is a possibility suggested to us by our prvious finding of reduced self reported 'postural disorder' by Vitamin B6 (Field et al., 2024), and by existing literature about the role of Vitamin B6 in muscle function.

Conditions

Interventions

TypeNameDescription
DRUGPyridoxal-5'-Phosphate supplement100mg PLP in the form of a tablet, taken once a day for 1 week
DRUGPlacebo SupplementationPlacebo supplement in the form of a capsule.

Timeline

Start date
2026-02-01
Primary completion
2026-11-01
Completion
2026-11-01
First posted
2026-03-13
Last updated
2026-03-17

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT07469462. Inclusion in this directory is not an endorsement.